Primary Site >> Pancreatic Cancer
Gene >> SFRP1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. PMID: 12839967 |
Ref: Comparative genomics on SFRP2 orthologs. PMID: 16077992 |
Ref: Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms. PMID: 16670620 Ref: Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). PMID: 17089004 |
Ref: CpG island methylation profile of pancreatic intraepithelial neoplasia. PMID: 18157091 Ref: Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. PMID: 18298655 Ref: Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer. PMID: 18706212 |
Ref: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. PMID: 19424592 Ref: Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. PMID: 19513567 |
Ref: Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer. PMID: 22414467 |
Ref: Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. PMID: 23555160 |
Ref: Expression of estrogen-induced genes and estrogen receptor beta in pancreatic neuroendocrine tumors: implications for targeted therapy. PMID: 25058880 |
Ref: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/beta-catenin pathway. PMID: 26485754 |
Ref: Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3beta and sFRP1 in human pancreatic carcinoma. PMID: 27459115 Ref: Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma. PMID: 27891190 |
Ref: Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers. PMID: 28148542 Ref: Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. PMID: 29212200 |